BioNTech
NEWS
Newly-published studies suggest currently authorized COVID-19 vaccines may be effective for protecting against new and emerging variants of the novel coronavirus, while booster doses of these vaccines may improve the overall efficiencies of these immunizations at combating these variants.
Here’s a look at Pfizer-BioNTech, Novavax and the COVID-19 vaccine’s sales, approval in children, additional trials, potential of booster shots, and more.
Please check out the biopharma industry’s COVID-19 stories that are trending for May 4, 2021.
The U.S. FDA is expected to give the go-ahead for Pfizer and BioNTech’s COVID-19 vaccine for adolescents ages 12 and older within the week.
BioSpace takes an in-depth look at the Top 25 of Q1. You should be aware of these biopharma companies as they hold a great future ahead. So, check them out.
Please check out the biopharma industry’s COVID-19 stories that are trending for April 27, 2021.
Sanofi will use its manufacturing capabilities to support the development of 200 million doses of the Moderna COVID-19 vaccine beginning in September.
Biopharma and life sciences companies from around the globe provide updates on their businesses and pipelines.
Please check out the biopharma industry’s COVID-19 stories that are trending for April 13, 2021.
JOBS
IN THE PRESS